According to Takeda Pharmaceutical's latest financial reports and stock price the company's current number of shares outstanding is 3,109,048,000. At the end of 2022 the company had 3,109,048,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2022 | 3.10 B | -0.68% |
2021 | 3.13 B | 0.12% |
2020 | 3.12 B | 0.36% |
2019 | 3.11 B | 98.57% |
2018 | 1.56 B | 0.43% |
2017 | 1.56 B | 0.04% |
2016 | 1.56 B | -0.34% |
2015 | 1.56 B | -0.29% |
2014 | 1.57 B | -0.48% |
2013 | 1.57 B | 0.01% |
2012 | 1.57 B | 0% |
2011 | 1.57 B | 0% |
2010 | 1.57 B | -0% |
2009 | 1.57 B | 0% |
2008 | 1.57 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 2,598,734,075 | -16.41% | ๐บ๐ธ USA |
![]() Novartis NVS | 2,083,000,000 | -33.00% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | 5,634,000,000 | 81.21% | ๐บ๐ธ USA |
![]() Amgen AMGN | 534,000,000 | -82.82% | ๐บ๐ธ USA |
![]() Sanofi SNY | 2,498,600,000 | -19.63% | ๐ซ๐ท France |
![]() Merck MRK | 2,538,000,000 | -18.37% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | 2,022,000,000 | -34.96% | ๐ฌ๐ง UK |
![]() Seagen
SGEN | 186,889,000 | -93.99% | ๐บ๐ธ USA |
![]() Dr. Reddy's RDY | 166,136,010 | -94.66% | ๐ฎ๐ณ India |